Scholarlink

<p>Interleukin-15 (IL-15) is a pleiotropic cytokine of the common γ-chain (γc) family, playing a central role in the development, survival, and activation of natural killer (NK) cells and memory CD8<sup>+</sup> T cells. Its tightly regulated expression is essential for maintaining immune homeostasis, while dysregulation of IL-15 signaling has been implicated in the pathogenesis of various autoimmune and chronic inflammatory diseases. This review explores the structural features, receptor complex, and signaling mechanisms of IL-15, emphasizing its immunomodulatory functions in both innate and adaptive immunity. We highlight the role of IL-15 in the initiation and progression of autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis (MS), type 1 diabetes, celiac disease, inflammatory bowel disease, psoriasis, and ankylosing spondylitis. Special focus is given to IL-15-mediated activation of tissue-resident memory T cells (TRM), cytotoxic CD8<sup>+</sup> T cells, and NK cells, which contribute to tissue-specific autoimmunity and sustained inflammation. Furthermore, we summarize emerging therapeutic strategies targeting IL-15 and its receptor complex, including monoclonal antibodies, receptor antagonists, and cytokine fusion proteins. Clinical trials and preclinical data suggest that IL-15 blockade may offer a promising therapeutic avenue in autoimmune diseases, particularly in refractory or relapsing forms. The review concludes with future directions for integrating IL-15-targeted interventions into precision immunotherapy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Interleukin 15 and autoimmune disorders: pathophysiology, therapeutic potential, and clinical implications

  • 期刊论文

  • 发表日期：

    2025年10月17日

查看全文
  • Leila Darouni,
  • Fatemeh Tavassoli Razavi,
  • Esmaeil Yazdanpanah,
  • Niloufar Orooji,
  • Alireza Shadab,
  • Atena Emami,
  • Haniyeh Molavi,
  • Dariush Haghmorad

摘要

Interleukin-15 (IL-15) is a pleiotropic cytokine of the common γ-chain (γc) family, playing a central role in the development, survival, and activation of natural killer (NK) cells and memory CD8+ T cells. Its tightly regulated expression is essential for maintaining immune homeostasis, while dysregulation of IL-15 signaling has been implicated in the pathogenesis of various autoimmune and chronic inflammatory diseases. This review explores the structural features, receptor complex, and signaling mechanisms of IL-15, emphasizing its immunomodulatory functions in both innate and adaptive immunity. We highlight the role of IL-15 in the initiation and progression of autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis (MS), type 1 diabetes, celiac disease, inflammatory bowel disease, psoriasis, and ankylosing spondylitis. Special focus is given to IL-15-mediated activation of tissue-resident memory T cells (TRM), cytotoxic CD8+ T cells, and NK cells, which contribute to tissue-specific autoimmunity and sustained inflammation. Furthermore, we summarize emerging therapeutic strategies targeting IL-15 and its receptor complex, including monoclonal antibodies, receptor antagonists, and cytokine fusion proteins. Clinical trials and preclinical data suggest that IL-15 blockade may offer a promising therapeutic avenue in autoimmune diseases, particularly in refractory or relapsing forms. The review concludes with future directions for integrating IL-15-targeted interventions into precision immunotherapy.